PreprintAll rights reservedbioRxiv
A human-derived two-antibody cocktail confers prophylactic and therapeutic protection against authentic Mpox virus.
- 1The University of Texas Medical Branch
Related
- Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials
- Tc17-driven antibody-independent mucosal immunity is critical for protection against extracellular bacterial pneumonia
- Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity
- A tri-modular feline infectious peritonitis virus nanoparticle vaccine confers complete protection in female cats without detectable antibody-dependent enhancement
- From prophylactic mRNA vaccines against viral infections to therapeutic applications: regulatory science considerations for expanding mRNA platforms
BibTeX
@misc{kalveram2026humanderived,
title = {{A human-derived two-antibody cocktail confers prophylactic and therapeutic protection against authentic Mpox virus.}},
author = {B. Kalveram and A. Adam and J. Kapetshi and M. Weglarz and G. Babuadze and T. Wang and H. Fausther-Bovendo},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.31.748425},
url = {https://www.biorxiv.org/content/10.64898/2026.08.31.748425v1},
}
RIS
TY - UNPB
TI - A human-derived two-antibody cocktail confers prophylactic and therapeutic protection against authentic Mpox virus.
AU - B. Kalveram
AU - A. Adam
AU - J. Kapetshi
AU - M. Weglarz
AU - G. Babuadze
AU - T. Wang
AU - H. Fausther-Bovendo
PY - 2026
DA - 2026/08/31
PB - bioRxiv
DO - 10.64898/2026.08.31.748425
UR - https://www.biorxiv.org/content/10.64898/2026.08.31.748425v1
ER -